PSTV vs TECH · P/E 0.2, rev $5.8M vs P/E 65, rev $1.22B
Plus Therapeutics Inc (PSTV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PSTV currently screens at market cap $29.7M and trailing P/E 0.2. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PSTV and TECH stock pages for the full models.
Not investment advice.